^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    URO17™

    Company:
    Protean BioDiagnostics
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The URO17 test is is an immunocytochemical test based on a novel biomarker, with 100% sensitivity and 96% specificity for detecting bladder cancer from urine samples. Testing suggests that the URO17™ test could improve accuracy of cytology and cystoscopy in monitoring recurrence cases, and detection of new cases in patients with hematuria.
    Cancer:
    Bladder Cancer
    Method:
    Immunohistochemistry (IHC)